Jefferies uses 10 charts to emphasize that China's technology leadership is becoming a structural investment theme

Overview

This is a Jefferies Washington Strategy thematic research report that presents 10 of the most representative charts around “China technology leadership.” The report defines China's technological rise as a structural trend rather than a short-term cyclical fluctuation, with telecom, autos, and AI seen as early manifestations. The core recommendation is that investors should assess the impact of Chinese technological breakthroughs on Western equities while also considering direct allocation to China technology-related exposure.

Core views

The report's core judgment is that China has become the United States' most important and most credible near-peer competitor across multiple strategic technology dimensions, and in some areas has already taken the lead. Evidence includes the concentration of high-impact research institutions in China, the rapid rise in China's share of highly cited papers in critical technologies, PPP-based R&D spending surpassing the U.S., a commanding lead in patent application volume, DeepSeek usage exceeding leading U.S. frontier models, declining import dependence in China's strategic industries, a leading share in defense critical technology research, clean technology factory investment far above the U.S., and an overall capability second only to the U.S. across five major frontier fields: AI, biotechnology, semiconductors, space, and quantum.

Analysis framework

The report uses a cross-source chart and indicator comparison approach, placing research quality, R&D investment, intellectual property, AI model usage, trade dependence, defense technology research share, capital expenditure, a composite frontier technology index, and government space spending within a single framework to observe China-U.S. technology competition. Its focus is not on single-company earnings forecasts, but on using multidimensional data to show that China's improving technological capabilities are already influencing global asset allocation.

Methodology notes

• macro and thematic strategymulti-indicator framework for China-U.S. technology competition

  Measure national technological competitiveness across multiple dimensions including research, capital, industrial chains, applications, and government investment.

  The report does not rely on a single metric, but instead integrates data from Nature Index, ASPI, ITIF, WIPO, OpenRouter, Rhodium, BloombergNEF, Belfer Center, and Novaspace to form a structural judgment on China's technology leadership.

• technology competitiveness assessmentcritical and emerging technologies index

  Compare relative strength across frontier fields such as AI, biotechnology, semiconductors, space, and quantum.

  The Belfer Center 2025 Critical and Emerging Technologies Index shows the United States at about 84 and China at about 65, well ahead of Europe at about 42 and Japan at about 24, indicating that China is the only serious challenger to the U.S. in frontier technology.

• investment impact assessmentstructural disruption perspective

  Treat China's technological progress as a long-term variable that can affect industry profit pools and valuations.

  The report explicitly states that Chinese technological disruption is structural rather than cyclical, and recommends that investors assess both its impact on Western equities and direct exposure to Chinese technology.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• China technology-related equities and thematic exposure

  Assets that may directly benefit from the rise in China's technology leadership.

  Strengths

  R&D spending, patents, research papers, AI usage, clean technology capex, and industrial chain substitution provide multidimensional support.

  Weaknesses

  The report does not provide specific investable names, earnings forecasts, or valuation margin of safety.

  Comparison

  Relative to the U.S. and Europe, China has narrowed the gap or established a lead across multiple key technology and manufacturing investment indicators.

  Risks

  Geopolitics, export controls, policy changes, overseas investment restrictions, and valuation volatility.

• U.S. and Western technology equities

  May face competitive disruption from China's technological catch-up and industrial substitution.

  Strengths

  The United States still leads in the composite frontier technology index and government space spending.

  Weaknesses

  Relative to China, it is under pressure in share of highly cited papers, share of research in certain defense technologies, clean technology factory investment, and patent application scale.

  Comparison

  The report describes China as the only serious challenger to the U.S. in AI, biotechnology, semiconductors, space, and quantum.

  Risks

  Margin compression, loss of market share, supply chain reconfiguration, policy conflict, and valuation repricing.

• clean technology industrial chain

  China's much larger clean technology factory investment may reinforce its manufacturing and cost advantages.

  Strengths

  In 2025, mainland China's clean technology factory capex was about 12 times that of the United States, and it has maintained high investment since 2023.

  Weaknesses

  High capex may create risks of overcapacity and price competition.

  Comparison

  U.S. clean technology factory investment is still expected to remain in the single-digit billions of dollars through 2027.

  Risks

  Trade barriers, changes in subsidy policy, capacity utilization, and weaker-than-expected global demand.

• AI, semiconductors, biotechnology, space, and quantum themes

  The report treats these as the core sectors for measuring China-U.S. frontier technology competition.

  Strengths

  China ranks second globally in the composite index, significantly ahead of Europe and Japan.

  Weaknesses

  The U.S. total score remains above China, and some core technologies may still be constrained by export controls.

  Comparison

  United States about 84, China about 65, Europe about 42, Japan about 24.

  Risks

  Technological bottlenecks, regulatory restrictions, capital market volatility, and constrained international cooperation.

Key data

• global high-impact research institutions9 of the global top 10 in Nature Index 2026 are Chinese institutions, with the Chinese Academy of Sciences ranked No. 1.Used to support the judgment that Chinese research institutions lead in influence.
• share of highly cited papers in critical technologiesChina rose from about 5% in 2005 to about 47% in 2025; the United States fell from about 40% to about 9%.Source: ASPI Critical Technology Tracker.
• R&D spendingChina's PPP-adjusted R&D spending in 2024 was about $1.03 trillion, versus about $1.01 trillion for the United States.Estimated by ITIF; China's actual R&D spending has grown at more than 12% annually since 2004, more than three times the U.S. pace.
• patent applicationsChina filed about 1.8 million patent applications in 2024, versus about 503,000 for the United States and about 421,000 for Japan.WIPO data; China's total exceeds the next nine countries combined.
• DeepSeek usageOpenRouter standardized token volume reached about 8,600 by July 2026.The report says DeepSeek usage rose rapidly from nearly zero in early 2025 to above leading U.S. frontier models.
• import dependence in strategic industriesThe share of sub-industries where China's imports exceed exports by more than 2x has declined markedly since 2004 across eight strategic industries.Rhodium data, involving aerospace, advanced electronics, robotics, and power, among others.
• share of defense critical technology researchChina leads the United States in global research share across 18 critical defense fields.Including hypersonics, quantum computing, autonomous underwater vehicles, drones, and electronic warfare.
• clean technology factory investmentMainland China was about $104 billion in 2025 versus about $9 billion for the United States, a gap of about 12x.BloombergNEF data; China has averaged about $95 billion per year since 2023.
• composite frontier technology indexUnited States about 84, China about 65, Europe about 42, Japan about 24.Covers AI, biotechnology, semiconductors, space, and quantum.
• government space spendingChina was about $19.9 billion in 2024, the United States about $79.7 billion, Japan about $6.8 billion, EU/ESA about $6.7 billion, and Russia about $4.0 billion.Novaspace data; China is the world's second-largest government spender on space.

Impact & implications

The investment implication is that China's improving technological capabilities may reshape the global competitive landscape in technology, industry, energy, defense, and capital goods. For Western equities, the risk comes from competitive pressure exerted by Chinese companies in cost, scale, R&D speed, and supply chain completeness; for Chinese technology assets, structural technological progress may enhance long-term allocation value, though this still needs to be assessed alongside policy, geopolitics, export controls, and market investability.

Risks

• The report is thematic strategy research and does not include single-stock earnings forecasts, ratings, or target prices, so it cannot directly substitute for individual stock investment decisions.
• China-U.S. geopolitics, export controls, sanctions, and investment restrictions may affect the investability of China technology exposure.
• High-capex industries may experience overcapacity, price wars, or declining returns.
• Some indicators measure research or investment capability and do not necessarily translate into commercial profitability.
• The report relies on multiple third-party data sources, and differences in statistical scope and comparability may exist across methodologies.

What to watch

• Ongoing usage volumes and developer ecosystem changes for DeepSeek and other Chinese AI models on global platforms.
• Commercialization progress in China's semiconductors, quantum, space, biotechnology, and defense technologies.
• Export controls, investment restrictions, and industrial policy responses by the United States and its allies toward China's technology sectors.
• Whether China's clean technology capex translates into sustained export share and profitability.
• The conversion efficiency from high-impact papers, patents, and R&D spending into corporate revenue, profit, and global market share.